Immunomodulatory Activity and Therapeutic Potential of the Filarial Nematode Secreted Product, ES-62

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 666)


ES-62 is a protein that is actively secreted by filarial nematodes during parasitism of the vertebrate host. The molecule is able to direcdy interact with a number of cells of the immune system including B-lymphocytes, dendritic cells, macrophages and mast cells. Interaction appears to be dependent on complexing with TLR4 and results in modulation of the activity of a number of signal transduction molecules including MAP kinases, PI-3 kinase and NF-κB. Immunomodulatory activity of ES-62 appears to be largely due to the presence of phosphorylcholine (PC) moieties covalendy attached to N-type glycans. The net effect of ES-62’s interaction with the immune system is the generation of an antiinflammatory immunological phenotype. As a consequence of this, ES-62 demonstrates striking drug-like activity in models of disease associated with aberrant inflammation, in particular those associated with autoimmunity and allergy.


Mast Cell Sphingosine Kinase Filarial Nematode Airway Hypersensitivity Parasite Immunol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Strachan DP. Hay fever, hygiene and household size. BMJ 1989; 299(6710):1259–1260.CrossRefPubMedGoogle Scholar
  2. 2.
    Sewell DL, Reinke EK, Hogan LH et al. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol Lett 2002; 82(1–2):101–110.CrossRefPubMedGoogle Scholar
  3. 3.
    Beighton P, Solomon L, Valkenburg HA. Rheumatoid arthritis in a rural south african negro population. Ann Rheum Dis 1975; 34(2):136–141.CrossRefPubMedGoogle Scholar
  4. 4.
    Dunne DW, Cooke A. A worms eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 2005; 5(5):420–426.CrossRefPubMedGoogle Scholar
  5. 5.
    Maizels R M. Infections and allergy—helminths, hygiene and host immune regulation. Curr Opin Immunol 2005; 17(6); 656–661.CrossRefPubMedGoogle Scholar
  6. 6.
    WHO. Filariasis. Geneva: World Health Organisation, 2000.Google Scholar
  7. 7.
    Subramanian S, Stolk WA, Ramaiah KD et al. The dynamics of wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology 2004; 128(Pt 5):467–482.CrossRefPubMedGoogle Scholar
  8. 8.
    King CL. Transmission intensity and human immune responses to lymphatic filariasis. Parasite Immunol 2001; 23(7):363–371.CrossRefPubMedGoogle Scholar
  9. 9.
    Brattig NW Pathogenesis and host responses in human onchocerciasis: impact of onchocerca filariae and wolbachia endobacteria. Microbes Infect 2004; 6(1):113–128.CrossRefPubMedGoogle Scholar
  10. 10.
    Harnett W, Grainger M, Kapil A et al. Origin, kinetics of circulation and fate in vivo of the major excretory-secretory product of Acanthocheilonema viteae. Parasitol Today 1989; 99:229–239.Google Scholar
  11. 11.
    Stepek G, Auchie M, Tate R et al. Expression of the filarial nematode phosphorylcholine-containing glycoprotein, ES62, is stage specific. Parasitology 2002; 125(Pt 2):155–164.PubMedGoogle Scholar
  12. 12.
    Stepek G, Houston KM, Goodridge HS et al. Stage-specific and species-specific differences in the production of the mRNA and protein for the filarial nematode secreted product, ES-62. Parasitol Today 2004; 128(Pt 1):91–98.Google Scholar
  13. 13.
    Harnett W, Harnett MM, Byron O. Structural/functional aspects of ES-62—a secreted immunomodulatory phosphorylcholine-containing filarial nematode glycoprotein. Curr Protein Pept Sci 2003; 4(1):59–71.CrossRefPubMedGoogle Scholar
  14. 14.
    Harnett W, Houston KM, Tate R et al. Molecular cloning and demonstration of an aminopeptidase activity in a filarial nematode glycoprotein. Mol Biochem Parasitol 1999; 104(1):11–23.CrossRefPubMedGoogle Scholar
  15. 15.
    Taylor A. Aminopeptidases: towards a mechanism of action. Trends in Biochemical Sciences 1993; 18(5):167–171.PubMedGoogle Scholar
  16. 16.
    Acosta D, Goni F, Carmona C. Characterization and partial purification of a leucine aminopeptidase from fasciola hepatica. Journal of Parasitology 1998; 84(1):1–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Harnett W, Houston KM, Amess R et al. Acanthocheilonema viteae: phosphorylcholine is attached to the major excretory-secretory product via an N-linked glycan. Exp Parasitol 1993; 77:498–502.CrossRefPubMedGoogle Scholar
  18. 18.
    Ackerman CJ, Harnett MM, Harnett W et al. A solution structure of the filarial nematode immunomodulatory protein, ES-62. Biophys J 2003; 84(1):489–500.CrossRefPubMedGoogle Scholar
  19. 19.
    Harnett W, Harnett MM. Phosphorylcholine: Friend or foe of the immune system? Immunology Today 1999; 20(3):125–129.CrossRefPubMedGoogle Scholar
  20. 20.
    Deehan M, Harnett M, Harnett W. A filarial nematode secreted product differentially modu-lates expression and activation of protein kinase C isoforms in B-lymphocytes. J Immunol 1997; 159(12):6105–6111.PubMedGoogle Scholar
  21. 21.
    Deehan MR, Frame MJ, Parkhouse RM et al. A phosphorylcholine-containing filarial nematode-secreted product disrupts B-lymphocyte activation by targeting key proliferative signaling pathways. J Immunol 1998; 160(6):2692–2699.PubMedGoogle Scholar
  22. 22.
    Deehan MR, Harnett W, Harnett MM. A filarial nematode-secreted phosphorylcholine-containing glycoprotein uncouples the B-cell antigen receptor from extracellular signal-regulated kinase-mitogen-activated protein kinase by promoting the surface Ig-mediated recruitment of Src homology 2 domain-containing tyrosine phosphatase-1 and Pac-1 mitogen-activated kinase-phosphatase. Journal of Immunology 2001; 166(12):7462–7468.Google Scholar
  23. 23.
    Harnett W, Harnett MM. Inhibition of murine B-cell proliferation and down-regulation of protein kinase C levels by a phosphorylcholine-containing filarial excretory-secretory product. J Immunol 1993; 151:4829–4837.PubMedGoogle Scholar
  24. 24.
    Harnett MM, Deehan MR, Williams DM et al. Induction of signalling anergy via the T-cell receptor in cultured Jurkat T-cells by pre-exposure to a filarial nematode secreted product. Parasite Immunology 1998; 20(11):551–563.CrossRefPubMedGoogle Scholar
  25. 25.
    Wilson EH, Katz E, Goodridge HS et al. In vivo activation of murine peritoneal Bl cells by the filarial nematode phosphorylcholine-containing glycoprotein ES-62. Parasite Immunol 2003; 25(8–9):463–466.CrossRefPubMedGoogle Scholar
  26. 26.
    Whelan M, Harnett MM, Houston KM et al. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J Immunol 2000; 164(12):6453–6460.PubMedGoogle Scholar
  27. 27.
    Goodridge HS, Wilson EH, Harnett W et al. Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J Immunol 2001; 167:940–945.PubMedGoogle Scholar
  28. 28.
    Melendez AJ, Harnett MM, Pushparaj PN et al. Inhibition of FcepsilonRI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat Med 2007; 13(11):1375–1381.CrossRefPubMedGoogle Scholar
  29. 29.
    Houston KM, Wilson EH, Eyres L et al. Presence of phosphorylcholine on a filarial nematode protein influences immunoglobulin G subclass response to the molecule by an interleukin-10-dependent mechanism. Infect Immun 2000; 68(9):5466–5468.CrossRefPubMedGoogle Scholar
  30. 30.
    Marshall FA, Garside P, Harnett W et al. ES-62, an immunomodulator secreted by filarial nematodes suppresses clonal expansion and skews effector function of heterologous antigen-specific T-cells in vivo. J Immunol 2005; 175:5817–5826.PubMedGoogle Scholar
  31. 31.
    Afzali B, Lombardi G, Lechler RI et al. The role of T helper 17 (Thl7) and regulatory T-cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148(1):32–46.PubMedGoogle Scholar
  32. 32.
    Lubberts E. IL-17/Thl7 targeting: on the road to prevent chronic destructive arthritis? Cytokine 2008; 41(2):84–91.CrossRefPubMedGoogle Scholar
  33. 33.
    Linden A. Rationale for targeting interleukin 17 in the lungs. Curr Opin Investig Drugs 2003; 4(11):1304–1312.PubMedGoogle Scholar
  34. 34.
    Goodridge HS, Marshall FA, Else KJ et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol 2005; 174(1):284–293.PubMedGoogle Scholar
  35. 35.
    Houston K, Wilson EH, Eyres L et al. The presence of phosphorylcholine on a filarial nematode protein influences the IgG subclass response to a molecule and by a mechanism dependent on IL-10. Infect Immunity 2000; 68(9):5466–5468.CrossRefGoogle Scholar
  36. 36.
    Harnett MM, Kean DE, Boitelle A et al. The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis. Ann Rheum Dis 2008; 67(4); 518–523.CrossRefPubMedGoogle Scholar
  37. 37.
    Goodridge HS, McGuiness S, Houston KM et al. Phosphorylcholine mimics the effects of ES-62 on macrophages and dendritic cells. Parasite Immunol 2007; 29(3):127–137.CrossRefPubMedGoogle Scholar
  38. 38.
    Goodridge HS, Deehan MR, Harnett W et al. Subversion of immunological signalling by a filarial nematode phosphorylcholine-containing secreted product. Cell Signal 2005; 17(1):11–16.CrossRefPubMedGoogle Scholar
  39. 39.
    Goodridge HS, Stepek G, Harnett W et al. Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62. Immunology 2005; 115(3):296–304.CrossRefPubMedGoogle Scholar
  40. 40.
    Ronnelid J, Berg L, Rogberg S et al. Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: enhanced activity in synovial fluid compared to blood. Br J Rheumatol 1998; 37(1):7–14.CrossRefPubMedGoogle Scholar
  41. 41.
    Chabaud M, Durand JM, Buchs N et al. Human interleukin-17: A T-cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999; 42:963–970.CrossRefPubMedGoogle Scholar
  42. 42.
    Gracie JA, Forsey RJ, Chan WL et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104(10):1393–1401.CrossRefPubMedGoogle Scholar
  43. 43.
    Taylor PC, Williams RO, Maini RN. Immunotherapy for rheumatoid arthritis. Curr Opin Immunol 2001; 13(5):611–616.CrossRefPubMedGoogle Scholar
  44. 44.
    Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397–440.CrossRefPubMedGoogle Scholar
  45. 45.
    Mclnnes IB, Leung BP, Harnett M et al. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol 2003; 171(4):2127–2133.Google Scholar
  46. 46.
    Mclnnes IB, Gracie JA, Harnett M et al. New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis 2003; 62(Suppl 2):ii51–54.Google Scholar
  47. 47.
    Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992; 89(20):9784–9788.CrossRefPubMedGoogle Scholar
  48. 48.
    Al-Riyami L, Egan C, Bradley JE et al. Failure of ES-62 to inhibit T-helper Type 1 responses to other filarial nematode antigens. Parasite Immunol 2008; 30(5):304–308.CrossRefPubMedGoogle Scholar
  49. 49.
    Houston KM, Harnett W. Structure and synthesis of nematode phosphorylcholine-containing glyco-conjugates. Parasitology 2004; 129(Pt 6):655–661.CrossRefPubMedGoogle Scholar
  50. 50.
    Kean DE, Ohtsuka I, Sato K et al. Dissecting ascaris glycosphingolipids for immunomodulatory moieties—the use of synthetic structural glycosphingolipid analogues. Parasite Immunol 2006; 28(3):69–76.CrossRefPubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2009

Authors and Affiliations

  1. 1.Strathclyde Institute of Pharmacy and Biomedical SciencesUniversity of StrathclydeGlasgowUK
  2. 2.Division of Inflammation Infection and ImmunityUniversity of GlasgowGlasgowUK

Personalised recommendations